$BSGM The Company has achieved proof of concept validation through UCLA EP & Animal Labs ongoing from May 2013. BioSig is collaborating with several of the nation's most prestigious cardiac arrhythmia centers to develop, refine and, ultimately, commercialize the PURE EP System, Including: Texas Cardiac Arrhythmia Institute UCLA Cardiac Arrhythmia Center U.H. Case Medical Center in Cleveland William Beaumont Hospital in Michigan Mount Sinai Medical Center in NY Mayo Clinic in Minnesota.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.